Drug Profile
KITE 037
Alternative Names: KITE-037Latest Information Update: 28 Feb 2023
Price :
$50
*
At a glance
- Originator Kite Pharma
- Class CAR-T cell therapies; Gene therapies; Immunotherapies
- Mechanism of Action Immunologic cytotoxicity; T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer